UltiSynq Defibrillation lead; SurGrip Suture Sleeve Accessory
ABBOTT MEDICAL · Decision date Nov 5, 2026
What did the FDA approve?
FDA record P950022/S153 is an approved supplement to PMA P950022 for Abbott Medical, not a new PMA. The supplied record states approval for the UltiSynq™ Defibrillation lead and the SurGrip™ Suture Sleeve Accessory, so the action is tied to those named components rather than to a new device system scope.
The supplement type is “Normal 180 Day Track,” and the listed reason is “Change Design/Components/Specifications/Material.” The source does not describe the exact design, component, specification, or material changes, so the specific modified item beyond those field labels is not stated in the supplied record.
FDA approval order statement
approval for UltiSynq Defibrillation lead and the SurGrip Suture Sleeve Accessory
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 5, 2026
- FDA change category
- Change Design/Components/Specifications/Material
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P950022/S153
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- LWS
- Decision code
- APPR
- Decision date
- Nov 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable cardioverter defibrillator (non-CRT).
- Applicant
- Abbott Medical
- Product code
- LWS
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P950022. Subsequent supplements may change the device or its indications.
FDA decision timeline
P950022 · Original PMA
TVL(TM) LEAD SYSTEM
P950022/S153 received
Application receipt date recorded by FDA.
P950022/S153 · FDA decision
Normal 180 Day Track
Timeline entries are records held by MedtechLedger for P950022. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P950022
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
TVL(TM) LEAD SYSTEMP950022 | ABBOTT MEDICAL | PMA approval | May 10, 1996 | FDA |
Explore the linked device profile
Other records with product code LWS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Nov 4, 2026 | FDA | |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S967 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 29, 2026 | FDA |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 9, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 15900 Valley View Ct., Sylmar, CA, 91335
Sources and methodology
- Original FDA record: P950022/S153
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


